EVA Pharma
Biologics Quality Control Section Head
- LocationEgypt
- TypeFull-time
- Posted2026-11-03
- Valid through2026-11-17
- BudgetUSD 600–900 / month
- Long-termYes
About this task
Job Summary
Lead laboratory operations to ensure the quality, safety, and compliance of biological and biosimilar products through analytical testing and biological activity assessment.
Key Responsibilities:
- Lead QC testing and characterization of biological and biosimilar products in compliance with GMP requirements and approved specifications.
- Oversee analytical testing using LC-MS/QTOF, HPLC, ELISA, IEF, SDS-PAGE, and microplate readers.
- Lead bioassay testing for biological activity and potency, including assay execution, data interpretation, troubleshooting, and validation.
- Manage analytical method transfer, verification, validation, and troubleshooting for new and existing products.
- Review analytical data and lead investigations into OOS/OOT results, deviations, and laboratory incidents, ensuring effective root-cause analysis and CAPA implementation.
- Oversee stability testing and evaluation of biological product stability data.
- Ensure compliance with GMP, data integrity requirements, and applicable regulatory standards.
- Lead and develop the QC team, ensuring timely testing, laboratory efficiency, and continuous improvement.
- Support internal and external audits and regulatory inspections.
Requirements:
- Bachelor’s degree in Science, Biochemistry, Biotechnology, or a related field.
- 6+ years of experience in quality control or quality assurance within the pharmaceutical or related industry.
- Hands-on experience in bioassay testing, biological activity and potency assessment, and assay validation is essential.
- Practical experience with LC-MS/QTOF, HPLC, ELISA, IEF, SDS-PAGE, and microplate reader-based techniques.
- Strong knowledge of GMP, data integrity, laboratory investigations, and pharmaceutical quality systems.
- Previous experience in team leadership or supervision is preferred.
Employment Type: Full-time.